IL153660A0 - Method for introducing nucleic acid and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current - Google Patents

Method for introducing nucleic acid and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current

Info

Publication number
IL153660A0
IL153660A0 IL15366001A IL15366001A IL153660A0 IL 153660 A0 IL153660 A0 IL 153660A0 IL 15366001 A IL15366001 A IL 15366001A IL 15366001 A IL15366001 A IL 15366001A IL 153660 A0 IL153660 A0 IL 153660A0
Authority
IL
Israel
Prior art keywords
nucleus
biologically active
eukaryotic cells
nucleic acid
electrical current
Prior art date
Application number
IL15366001A
Other languages
English (en)
Original Assignee
Amaxa Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amaxa Gmbh filed Critical Amaxa Gmbh
Publication of IL153660A0 publication Critical patent/IL153660A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL15366001A 2000-06-27 2001-06-27 Method for introducing nucleic acid and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current IL153660A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10031179A DE10031179A1 (de) 2000-06-27 2000-06-27 Verfahren zur Einbringung von Nukleinsäuren und anderen biologisch aktiven Molekülen in den Kern höherer eukaryontischer Zellen mit Hilfe elektrischen Stroms
PCT/EP2001/007348 WO2002000871A2 (de) 2000-06-27 2001-06-27 Verfahren zur einbringung von nukleinsäuren und anderen biologisch aktiven molekülen in der kern höherer eukaryontischer zellen mit hilfe elektrischen stroms

Publications (1)

Publication Number Publication Date
IL153660A0 true IL153660A0 (en) 2003-07-06

Family

ID=7646911

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15366001A IL153660A0 (en) 2000-06-27 2001-06-27 Method for introducing nucleic acid and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current

Country Status (11)

Country Link
US (1) US20040014220A1 (xx)
EP (1) EP1297119B9 (xx)
JP (1) JP4794111B2 (xx)
CN (1) CN100381176C (xx)
AT (1) ATE282090T1 (xx)
AU (2) AU2001281911B2 (xx)
CA (1) CA2414542C (xx)
DE (2) DE10031179A1 (xx)
ES (1) ES2232653T3 (xx)
IL (1) IL153660A0 (xx)
WO (1) WO2002000871A2 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4070611B2 (ja) 2001-04-23 2008-04-02 アマクサ アーゲー 電気穿孔法用の緩衝溶液およびその使用を含む方法
US20060040249A1 (en) * 2002-09-26 2006-02-23 Manfred Auer Screening method involving transfected primary cells
US7598071B2 (en) * 2004-07-09 2009-10-06 The United States Of America As Represented By The Department Of Health And Human Services Infectious clone of human parvovirus B19 and methods
EP1741778B1 (de) * 2005-07-07 2007-12-26 Amaxa AG Verfahren zur Behandlung geringer Volumina mit elektrischem Strom
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
US8129187B2 (en) 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
MX2008007654A (es) 2005-12-13 2008-09-26 Univ Kyoto Factor de reprogramacion nuclear.
DE102007005909A1 (de) 2007-02-01 2008-08-14 Amaxa Ag Verfahren zur Kontrolle eines mit Elektroden versehenen Behältnissen
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
US9213999B2 (en) 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
ES2722198T3 (es) 2008-05-02 2019-08-08 Univ Kyoto Método de reprogramación nuclear
EP2208778A1 (de) 2009-01-20 2010-07-21 Lonza Cologne AG Verfahren und Vorrichtung zur elektrischen Behandlung von Reaktionsräumen
WO2012098260A1 (en) 2011-01-21 2012-07-26 Axiogenesis Ag A non-viral system for the generation of induced pluripotent stem (ips) cells
US10093706B2 (en) 2017-01-30 2018-10-09 Indiana University Research And Technology Corporation Dominant positive hnRNP-E1 polypeptide compositions and methods

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849355A (en) * 1985-01-08 1989-07-18 Wong Tai Kin Method of transferring genes into cells
US4750100A (en) * 1986-06-06 1988-06-07 Bio-Rad Laboratories Transfection high voltage controller
US5098843A (en) * 1987-06-04 1992-03-24 Calvin Noel M Apparatus for the high efficiency transformation of living cells
US5128257A (en) * 1987-08-31 1992-07-07 Baer Bradford W Electroporation apparatus and process
CA1327174C (en) * 1988-10-05 1994-02-22 Youssef Mouneimne Electro-insertion of proteins into animal cell membranes
BE1004328A3 (fr) * 1990-05-16 1992-11-03 Scient Equipment Design & Dev Procede et dispositif de permeabilisation de cellules vivantes.
CA2019758C (en) * 1990-06-25 2001-09-04 Kevin L. Firth Improved electroporation device and method
WO1992006185A1 (en) * 1990-09-27 1992-04-16 The United States Of America, Represented By The Secretary, U.S. Department Of Commerce Method of electroporation using bipolar oscillating electric fields
US5273525A (en) * 1992-08-13 1993-12-28 Btx Inc. Injection and electroporation apparatus for drug and gene delivery
US5627023A (en) * 1993-03-29 1997-05-06 Duke University Suppressor of HIV replication and transcription
US6103084A (en) * 1995-06-06 2000-08-15 Eppendorf Netheler-Hinz Gmbh Apparatus for electroporation
US5869326A (en) * 1996-09-09 1999-02-09 Genetronics, Inc. Electroporation employing user-configured pulsing scheme
EP0866123B1 (de) * 1997-03-21 2005-03-16 Eppendorf Ag Verfahren und Schaltungsanordnung zur Elektropermeation oder Elektroporation von lebenden Zellen
SE9704076D0 (sv) * 1997-11-06 1997-11-06 Holdingbolaget Vid Goeteborgs Method for permeabilisation of cell structures and use thereof
WO1999036563A1 (en) * 1998-01-14 1999-07-22 Emed Corporation Electrically mediated cellular expression
AU5898599A (en) * 1998-08-19 2000-03-14 Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for genomic modification
US6150148A (en) * 1998-10-21 2000-11-21 Genetronics, Inc. Electroporation apparatus for control of temperature during the process
EP2105124A1 (de) * 2008-03-26 2009-09-30 Bayer MaterialScience AG Sonnenschutz-Zusammensetzungen

Also Published As

Publication number Publication date
WO2002000871A2 (de) 2002-01-03
EP1297119B9 (de) 2005-03-23
AU2001281911B2 (en) 2005-03-10
CA2414542C (en) 2012-01-17
EP1297119A2 (de) 2003-04-02
US20040014220A1 (en) 2004-01-22
ATE282090T1 (de) 2004-11-15
CN100381176C (zh) 2008-04-16
AU8191101A (en) 2002-01-08
DE10031179A1 (de) 2002-01-31
CN1531591A (zh) 2004-09-22
EP1297119B1 (de) 2004-11-10
JP4794111B2 (ja) 2011-10-19
DE50104496D1 (de) 2004-12-16
JP2004501640A (ja) 2004-01-22
CA2414542A1 (en) 2002-12-27
ES2232653T3 (es) 2005-06-01
WO2002000871A3 (de) 2002-10-17

Similar Documents

Publication Publication Date Title
IL153660A0 (en) Method for introducing nucleic acid and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current
WO2004080533A8 (en) Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
IL148152A0 (en) Sequence-specific dna recombination in eukaryotic cells
PL337583A1 (en) Improved method of transferring nucleic acid to a striated muscle and connection enabling accomplishment of this method
AU1059399A (en) Method for electro-permeabilisation of individual cellular and organellar structures and use thereof
EP0827410A4 (en) METHOD FOR INTRODUCING AND EXPRESSING GENES IN ANIMAL CELLS
ATE346156T1 (de) Umkehrtransfektionsverfahren
FI880899A (fi) Oleellisesti puhdas DNA ja RNA ja menetelmä erytropoietiinin ekspressoimiseksi
IL158514A0 (en) Buffer solution for electroporation and a method comprising the use of the same
US8058043B2 (en) Non invasive method of electroporation mediated by carbon nanotubes and device for putting the method into practice
ATE391185T1 (de) Verfahren zur einbringung von nukleinsäuren und anderen biologisch aktiven molekülen in den kern höherer eukaryontischer zellen mit hilfe elektrischen stroms
DE69731317D1 (de) Neue carbonyl-reduktase, gene welche diese kodieren und methoden zu deren verwendung
WO1996018741A3 (en) Liposome-mediated transfection of central nervous system cells
IL180924A0 (en) Method for regulating cell proliferation and cell death
WO2002033111A3 (en) Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
AU2001281911A1 (en) Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current
WO2000022095A3 (en) Method and apparatus for direct in vivo gene transfer by electrotransfection
AU8818398A (en) Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agent
EP0763205A4 (en) NUCLEIC ACID SEQUENCES REGULATING THE EXPRESSION OF LUNG SPECIFIC GENES
JP4187060B2 (ja) 細胞処理方法
JP2005065561A (ja) 血管壁細胞への遺伝子の導入方法
WO1999061067A8 (en) Gene expression method
WO2000014113A3 (en) Method of stimulating prosaposin receptor activity
WO2001007639A3 (en) Selectable marker gene
US20030216784A1 (en) Cellular electromanipulation waveforms